search
Back to results

RehabGBs: Rehabilitation in People With Guillain-Barré Syndrome (RehabGBs)

Primary Purpose

Guillain-Barré Syndrome

Status
Recruiting
Phase
Not Applicable
Locations
Portugal
Study Type
Interventional
Intervention
Inpatient Rehabilitation
Inspiratory muscle training
Sponsored by
Centro de Reabilitacao do Norte
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Guillain-Barré Syndrome focused on measuring Rehabilitation, Inspiratory Muscle Training

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ≥18 years
  • diagnosed with Guillain Barré Syndrome
  • willing to participate in an inpatient rehabilitation program
  • able to provide informed consent

Exclusion Criteria:

  • presence of significant cardiac and musculoskeletal diseases
  • tracheostomized patients
  • signs of cognitive impairment or current neoplastic or immunological disease which may preclude their participation in the rehabilitation program and participation in any other therapeutic intervention in addition to standard of care.

Sites / Locations

  • Centro de Reabilitação do NorteRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Inpatient Rehabilitation + Inspiratory Muscle Training

Inpatient Rehabilitation

Arm Description

The inpatient rehabilitation program included individualized, functional goal-oriented treatment, with approximately 5 hours of intervention a day, 5 days/week for a total of 6 weeks, with integrated rehabilitation care. The inspiratory muscle training included a 6 weeks intervention with electronic-controlled valve device

- The inpatient rehabilitation program included individualized, functional goal-oriented treatment, with approximately 5 hours of intervention a day, 5 days/week for a total of 6 weeks, with integrated rehabilitation care.

Outcomes

Primary Outcome Measures

Change in maximal inspiratory pressure
Respiratory muscle strength will be assessed with maximal respiratory pressure tests

Secondary Outcome Measures

Change in maximal expiratory pressure
Respiratory muscle strength will be assessed with maximal respiratory pressure tests
Change in Peak cough flow
Peak cough flow is the peak expiratory flow during a cough maneuver and will be measured three times and the best value will be used for analysis, using a hand-held peak flow meter.
Change in Nocturnal transcutaneous carbon dioxide and peripheral oxygen saturation
Nocturnal transcutaneous carbon dioxide will be recorded simultaneously for one night using a digital transcutaneous (SenTec, Switzerland)
Change in Medical Research Council - Manual Muscle Testing
This test is performed by applying manual resistance and the score is a sum of the strength of six muscle groups: 1) deltoid; 2) biceps; 3) wrist extensor; 4) iliopsoas; 5) quadriceps femoris; and 6) anterior tibial tested bilaterally, from grade 5 (i.e. the patient an move through the full range of motion against gravity and hold an isometric contraction against maximal resistance for 3 seconds) to grade 0 (i.e. no visible contraction)
Change in Functional Assessment of Chronic Illness Therapy-Fatigue Subscale
Functional Assessment of Chronic Illness Therapy-Fatigue Subscale is a multidimensional 13-item questionnaire assessing tiredness, weakness, and difficulty in handling daily activities due to fatigue, over the previous 7 days. Scores range from 0 to 52, with higher scores indicating less fatigue.
Change in Functional Independence Measure
Functional status will be measured with the Functional Independence Measure, an 18-item clinician reported scale which measures independent performance in self-care, sphincter control, transfers, locomotion, communication, and social cognition. Scores range from 1 to 7 (i.e. 1 = total assistance and 7 = complete independence). The score reflects burden of care in each area measured.

Full Information

First Posted
July 6, 2022
Last Updated
March 27, 2023
Sponsor
Centro de Reabilitacao do Norte
Collaborators
Aveiro University
search

1. Study Identification

Unique Protocol Identification Number
NCT05461898
Brief Title
RehabGBs: Rehabilitation in People With Guillain-Barré Syndrome
Acronym
RehabGBs
Official Title
RehabGBs: Rehabilitation in People With Guillain-Barré Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 1, 2023 (Actual)
Primary Completion Date
October 1, 2024 (Anticipated)
Study Completion Date
December 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centro de Reabilitacao do Norte
Collaborators
Aveiro University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Guillain-Barré syndrome (GBS) is a neurological disease characterized by an inflammation of peripheral nerves, which might be responsible for long-term disability. Respiratory muscle weakness is a complication of GBS and might be responsible for respiratory symptoms, inadequate secretion clearance or hypoventilation, with negative impact on daily life. Inspiratory muscle training has been applied in respiratory and neurological diseases and benefits have been observed in symptoms (e.g., dyspnoea), pulmonary function, exercise capacity and quality of life. Nevertheless, results of this intervention in people with GBS are yet unknown. Moreover, rehabilitation is a key player in the recovery of these highly complex patients, however, the interpretation of the magnitude of its effects has been limited by the absence of minimal clinically important differences for most outcome measures. To overcome these drawbacks, methodologically robust trials are needed to build evidence-based rehabilitation to improve clinical care on GBS. The primary aim of this project (RehabGBs) is to develop an inspiratory muscle training protocol - InspireGBs and assess its effects on respiratory muscle strength, peak cough flow, pulmonary function, dyspnoea, fatigue, functional status and quality of life in people with GBS, through a randomised controlled trial. Secondary aims are to: i) establish minimal clinically important differences of Functional Assessment of Chronic Illness Therapy-Fatigue Subscale, Medical Research Council - Manual Muscle Testing, Vital capacity, Maximal Inspiratory Pressure, Peak Cough Flow, Functional Independence Measure and Quality of Life for inpatient rehabilitation programmes of people with GBS ii) Evaluate the prevalence of nocturnal hypoventilation in GBS.
Detailed Description
Guillain-Barré syndrome (GBS) is an acute inflammatory demyelinating polyradiculoneuropathy and is the most common cause of acute flaccid paralysis. Its annual global incidence is between 0.8 - 1.9 cases per 100,000 people. GBS is usually preceded by infection or other immune stimulation that induces an aberrant autoimmune response targeting peripheral nerves and their spinal roots. It is characterized by rapid progressive bilateral muscle weakness of the lower limbs and/or arms, in combination with hyporeflexia or areflexia, and most patients reach their maximum disability within 2-4 weeks.Various phenotypes have been described, including acute inflammatory demyelinating polyradiculoneuropathy, acute motor axonal neuropathy, acute motor sensory axonal neuropathy and Miller-Fisher syndrome. Overall, the clinical course, severity and outcomes of people with GBS are highly heterogeneous. Significant disability, including incomplete recovery of motor (i.e., ambulation) and sensory function, as well as fatigue, pain, respiratory insufficiency and psychological distress might exist after the acute phase. But long-term significant impacts, two years after the onset, on daily activities, work, social activities and health-related quality of life have also been reported. The most often feature is an impairment of the motor capacity, but respiratory muscle weakness is a common complication in people with GBS and may result in decrease vital capacity, chest wall expansion and coughing strength, causing atelectasis and pulmonary infections. Therefore, it is generally accepted that respiratory muscle weakness causes increased morbidity and mortality, owing to the combination of poor airway protection, inadequate secretion clearance and hypoventilation. Previous studies already identified these clinical manifestations in acute GBS. However, prevalence of hypoventilation and inspiratory muscle weakness in subacute phase of GBS is still unknown. Early recognition and treatment of respiratory muscle weakness is important in people with GBS and physiotherapy interventions may be useful to successfully manage these patients. Inspiratory muscle training (IMT) is a cheap and free of side-effects therapeutic modality, which consists of breathing exercises using a pressure threshold device, that has been applied in several diseases. In patients with chronic obstructive pulmonary disease, IMT improve inspiratory muscle function, exertional dyspnoea and exercise capacity. In patients with neuromuscular disease, has been suggested that IMT increases inspiratory muscle strength and lung volumes, especially in those with muscular dystrophies. In addition, a randomized control trial concluded that IMT in acute patients increases inspiratory muscle strength and quality of life. However, there are no studies about rehabilitation approaches, such IMT, to improve symptoms (i.e. dyspnoea or fatigue), pulmonary function, functional status and quality of life in people with GBS. Rehabilitation, namely inpatient rehabilitation programmes, is therefore key for the recovery of symptoms, functional outcomes, community participation and quality of life of these highly complex patients. Nevertheless, insufficient high-quality literature, still precludes definitive conclusions about the effects of rehabilitation in people with GBS. Additionally, the interpretation of the magnitude of its effects is challenging due to the lack of minimal clinically important differences (MCIDs) for most outcome measures used in rehabilitation of people with GBS. A MCIDs is the smallest change in a measure that will be perceived as an important improvement for the patient. Such values constitute thresholds for clinical meaningfulness. Therefore, establishing MCIDs is essential to determine effectiveness of rehabilitation and guide clinical decision-making in the management of people with GBS. In conclusion, by developing and implementing RehabGBs, we will contribute to build evidence-based rehabilitation practices and optimise care in GBS, by: i) assessing the effects of IMT in people with GBS; ii) establishing minimal clinical important differences of rehabilitation outcome measures, to help clinicians better understand the magnitude of the effects of the intervention and determine effectiveness of rehabilitation in people with GBS; iii) evaluate the prevalence of nocturnal hypoventilation in people with GBS. Therefore, the primary aim of RehabGBs is to: 1. Evaluate, through a randomised controlled trial, the effects of InspireGBs - inspiratory muscle training protocol on respiratory muscle strength, peak cough flow, lung function, dyspnoea, fatigue, functional status and quality of life in people with GBS. The secondary aims of the project are to: Establish the MCIDs for rehabilitation programmes in people with GBS for Functional Assessment of Chronic Illness Therapy-Fatigue Subscale, Modified Borg Scale, Medical Research Council - Manual Muscle Testing, Vital capacity, Maximal Inspiratory pressure, Peak Cough Flow, Functional Independence Measure and EuroQol Five-Dimensional Questionnaire. Evaluate the prevalence of nocturnal hypoventilation in people with sub-acute GBS. Study Design & Intervention InspireGBs is an inspiratory muscle training programme which will be implemented to people with GBS for 6 weeks during an inpatient rehabilitation programme. They will receive IMT for 5 days/week using the PowerBreath KH2. This handheld device applies a constant resistance provided by a electronic-controlled valve. Training will be set initially at a load of approximately 50% of patients' maximal inspiratory mouth pressure. This initial load will be daily increased during the programme based on symptom scores (modified Borg dyspnoea Scale ratings of 4-6 of 10).Total daily training time will consist of 6 cycles of 30 breaths (3 cycles, twice daily). Patients will be recruited as described and randomly allocated by a computer-generated adaptive random allocation schedule (in a ratio 1:1) to either the experimental or control groups. All participants will receive the inpatient rehabilitation programme. This programme will be tailored to each patient, with approximately 5 hours of intervention/day for 5 days/week (typically for 14 weeks). An interdisciplinary team composed of physiotherapy; occupational therapy; speech and language therapy; and medical, pharmacological, nursery, psychology, clinical dietitian and social worker will be involved, as needed. Sample Size Estimation Based on an inspiratory muscle training study conducted in people with spinal cord injury, it is anticipated that a minimum of 64 participants (32 in each group) will be needed to detect a between-group difference of 10 cmH2O in the primary outcome measure (power=80%, α=0.05, 2-tailed). Since in GBS rehabilitation interventions dropout rates are around 15%, 74 participants will be needed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Guillain-Barré Syndrome
Keywords
Rehabilitation, Inspiratory Muscle Training

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
Single blind
Allocation
Randomized
Enrollment
74 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Inpatient Rehabilitation + Inspiratory Muscle Training
Arm Type
Experimental
Arm Description
The inpatient rehabilitation program included individualized, functional goal-oriented treatment, with approximately 5 hours of intervention a day, 5 days/week for a total of 6 weeks, with integrated rehabilitation care. The inspiratory muscle training included a 6 weeks intervention with electronic-controlled valve device
Arm Title
Inpatient Rehabilitation
Arm Type
Active Comparator
Arm Description
- The inpatient rehabilitation program included individualized, functional goal-oriented treatment, with approximately 5 hours of intervention a day, 5 days/week for a total of 6 weeks, with integrated rehabilitation care.
Intervention Type
Other
Intervention Name(s)
Inpatient Rehabilitation
Intervention Description
Standard inpatient rehabilitation program with a interdisciplinary team that included a physiotherapist who ensured muscle strength, balance, aerobic and functional training, an occupational therapist who provided training of basic and instrumental activities of daily living and education of energy conservation techniques and a a speech and language therapist for swallowing training.
Intervention Type
Other
Intervention Name(s)
Inspiratory muscle training
Intervention Description
Inspiratory muscle training protocol during 6 weeks with a electronic-controlled valve device
Primary Outcome Measure Information:
Title
Change in maximal inspiratory pressure
Description
Respiratory muscle strength will be assessed with maximal respiratory pressure tests
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
Change in maximal expiratory pressure
Description
Respiratory muscle strength will be assessed with maximal respiratory pressure tests
Time Frame
6 weeks
Title
Change in Peak cough flow
Description
Peak cough flow is the peak expiratory flow during a cough maneuver and will be measured three times and the best value will be used for analysis, using a hand-held peak flow meter.
Time Frame
6 weeks
Title
Change in Nocturnal transcutaneous carbon dioxide and peripheral oxygen saturation
Description
Nocturnal transcutaneous carbon dioxide will be recorded simultaneously for one night using a digital transcutaneous (SenTec, Switzerland)
Time Frame
6 weeks
Title
Change in Medical Research Council - Manual Muscle Testing
Description
This test is performed by applying manual resistance and the score is a sum of the strength of six muscle groups: 1) deltoid; 2) biceps; 3) wrist extensor; 4) iliopsoas; 5) quadriceps femoris; and 6) anterior tibial tested bilaterally, from grade 5 (i.e. the patient an move through the full range of motion against gravity and hold an isometric contraction against maximal resistance for 3 seconds) to grade 0 (i.e. no visible contraction)
Time Frame
6 weeks
Title
Change in Functional Assessment of Chronic Illness Therapy-Fatigue Subscale
Description
Functional Assessment of Chronic Illness Therapy-Fatigue Subscale is a multidimensional 13-item questionnaire assessing tiredness, weakness, and difficulty in handling daily activities due to fatigue, over the previous 7 days. Scores range from 0 to 52, with higher scores indicating less fatigue.
Time Frame
6 weeks
Title
Change in Functional Independence Measure
Description
Functional status will be measured with the Functional Independence Measure, an 18-item clinician reported scale which measures independent performance in self-care, sphincter control, transfers, locomotion, communication, and social cognition. Scores range from 1 to 7 (i.e. 1 = total assistance and 7 = complete independence). The score reflects burden of care in each area measured.
Time Frame
6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ≥18 years diagnosed with Guillain Barré Syndrome willing to participate in an inpatient rehabilitation program able to provide informed consent Exclusion Criteria: presence of significant cardiac and musculoskeletal diseases tracheostomized patients signs of cognitive impairment or current neoplastic or immunological disease which may preclude their participation in the rehabilitation program and participation in any other therapeutic intervention in addition to standard of care.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Miguel P Almeida, MSc
Phone
00351919523101
Email
miguelalmeida.ft@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Sofia A Viamonte, MSc
Phone
00351220901200
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alda S Marques, PhD
Organizational Affiliation
School of Health Sciences, University of Aveiro (ESSUA)
Official's Role
Study Director
Facility Information:
Facility Name
Centro de Reabilitação do Norte
City
Vila Nova de Gaia
ZIP/Postal Code
4405 - 565
Country
Portugal
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Miguel P Almeida, MSc
Phone
919523101
Email
miguelalmeida.ft@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31541214
Citation
Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, van Doorn PA, Dourado ME, Hughes RAC, Islam B, Kusunoki S, Pardo CA, Reisin R, Sejvar JJ, Shahrizaila N, Soares C, Umapathi T, Wang Y, Yiu EM, Willison HJ, Jacobs BC. Diagnosis and management of Guillain-Barre syndrome in ten steps. Nat Rev Neurol. 2019 Nov;15(11):671-683. doi: 10.1038/s41582-019-0250-9. Epub 2019 Sep 20.
Results Reference
background
PubMed Identifier
26948435
Citation
Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barre syndrome. Lancet. 2016 Aug 13;388(10045):717-27. doi: 10.1016/S0140-6736(16)00339-1. Epub 2016 Mar 2.
Results Reference
background
PubMed Identifier
25023340
Citation
van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014 Aug;10(8):469-82. doi: 10.1038/nrneurol.2014.121. Epub 2014 Jul 15.
Results Reference
background
PubMed Identifier
16323390
Citation
Forsberg A, Press R, Einarsson U, de Pedro-Cuesta J, Holmqvist LW. Disability and health-related quality of life in Guillain-Barre syndrome during the first two years after onset: a prospective study. Clin Rehabil. 2005 Dec;19(8):900-9. doi: 10.1191/0269215505cr918oa.
Results Reference
background
PubMed Identifier
29490222
Citation
Green C, Baker T, Subramaniam A. Predictors of respiratory failure in patients with Guillain-Barre syndrome: a systematic review and meta-analysis. Med J Aust. 2018 Mar 5;208(4):181-188. doi: 10.5694/mja17.00552.
Results Reference
background
PubMed Identifier
29627773
Citation
van den Berg B, Storm EF, Garssen MJP, Blomkwist-Markens PH, Jacobs BC. Clinical outcome of Guillain-Barre syndrome after prolonged mechanical ventilation. J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):949-954. doi: 10.1136/jnnp-2018-317968. Epub 2018 Apr 7.
Results Reference
background
PubMed Identifier
27506902
Citation
Walterspacher S, Kirchberger A, Lambeck J, Walker DJ, Schworer A, Niesen WD, Windisch W, Hamzei F, Kabitz HJ. Respiratory Muscle Assessment in Acute Guillain-Barre Syndrome. Lung. 2016 Oct;194(5):821-8. doi: 10.1007/s00408-016-9929-5. Epub 2016 Aug 9.
Results Reference
background
PubMed Identifier
16174943
Citation
Orlikowski D, Prigent H, Sharshar T, Lofaso F, Raphael JC. Respiratory dysfunction in Guillain-Barre Syndrome. Neurocrit Care. 2004;1(4):415-22. doi: 10.1385/NCC:1:4:415.
Results Reference
background
PubMed Identifier
24275453
Citation
Aslan GK, Gurses HN, Issever H, Kiyan E. Effects of respiratory muscle training on pulmonary functions in patients with slowly progressive neuromuscular disease: a randomized controlled trial. Clin Rehabil. 2014 Jun;28(6):573-81. doi: 10.1177/0269215513512215. Epub 2013 Nov 25.
Results Reference
background
PubMed Identifier
29914940
Citation
Charususin N, Gosselink R, Decramer M, Demeyer H, McConnell A, Saey D, Maltais F, Derom E, Vermeersch S, Heijdra YF, van Helvoort H, Garms L, Schneeberger T, Kenn K, Gloeckl R, Langer D. Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD. Thorax. 2018 Oct;73(10):942-950. doi: 10.1136/thoraxjnl-2017-211417. Epub 2018 Jun 18.
Results Reference
background
PubMed Identifier
31937553
Citation
Boswell-Ruys CL, Lewis CRH, Wijeysuriya NS, McBain RA, Lee BB, McKenzie DK, Gandevia SC, Butler JE. Impact of respiratory muscle training on respiratory muscle strength, respiratory function and quality of life in individuals with tetraplegia: a randomised clinical trial. Thorax. 2020 Mar;75(3):279-288. doi: 10.1136/thoraxjnl-2019-213917. Epub 2020 Jan 14.
Results Reference
background
PubMed Identifier
11555507
Citation
Koessler W, Wanke T, Winkler G, Nader A, Toifl K, Kurz H, Zwick H. 2 Years' experience with inspiratory muscle training in patients with neuromuscular disorders. Chest. 2001 Sep;120(3):765-9. doi: 10.1378/chest.120.3.765.
Results Reference
background
PubMed Identifier
27257003
Citation
Bissett BM, Leditschke IA, Neeman T, Boots R, Paratz J. Inspiratory muscle training to enhance recovery from mechanical ventilation: a randomised trial. Thorax. 2016 Sep;71(9):812-9. doi: 10.1136/thoraxjnl-2016-208279. Epub 2016 Jun 2.
Results Reference
background
PubMed Identifier
27904236
Citation
Simatos Arsenault N, Vincent PO, Yu BH, Bastien R, Sweeney A. Influence of Exercise on Patients with Guillain-Barre Syndrome: A Systematic Review. Physiother Can. 2016;68(4):367-376. doi: 10.3138/ptc.2015-58.
Results Reference
background
PubMed Identifier
22820829
Citation
Khan F, Amatya B. Rehabilitation interventions in patients with acute demyelinating inflammatory polyneuropathy: a systematic review. Eur J Phys Rehabil Med. 2012 Sep;48(3):507-22. Epub 2012 Jul 23.
Results Reference
background
PubMed Identifier
33567916
Citation
Sulli S, Scala L, Berardi A, Conte A, Baione V, Belvisi D, Leodori G, Galeoto G. The efficacy of rehabilitation in people with Guillain-Barre syndrome: a systematic review of randomized controlled trials. Expert Rev Neurother. 2021 Apr;21(4):455-461. doi: 10.1080/14737175.2021.1890034. Epub 2021 Feb 23.
Results Reference
background
PubMed Identifier
31953077
Citation
Malec JF, Ketchum JM. A Standard Method for Determining the Minimal Clinically Important Difference for Rehabilitation Measures. Arch Phys Med Rehabil. 2020 Jun;101(6):1090-1094. doi: 10.1016/j.apmr.2019.12.008. Epub 2020 Jan 15.
Results Reference
background
PubMed Identifier
21667009
Citation
Khan F, Pallant JF, Amatya B, Ng L, Gorelik A, Brand C. Outcomes of high- and low-intensity rehabilitation programme for persons in chronic phase after Guillain-Barre syndrome: a randomized controlled trial. J Rehabil Med. 2011 Jun;43(7):638-46. doi: 10.2340/16501977-0826.
Results Reference
background
PubMed Identifier
26338464
Citation
Ogna A, Quera Salva MA, Prigent H, Mroue G, Vaugier I, Annane D, Lofaso F, Orlikowski D. Nocturnal hypoventilation in neuromuscular disease: prevalence according to different definitions issued from the literature. Sleep Breath. 2016 May;20(2):575-81. doi: 10.1007/s11325-015-1247-2. Epub 2015 Sep 4.
Results Reference
background
PubMed Identifier
19362699
Citation
Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, Fernandez M. How we design feasibility studies. Am J Prev Med. 2009 May;36(5):452-7. doi: 10.1016/j.amepre.2009.02.002.
Results Reference
background
PubMed Identifier
30956204
Citation
Laveneziana P, Albuquerque A, Aliverti A, Babb T, Barreiro E, Dres M, Dube BP, Fauroux B, Gea J, Guenette JA, Hudson AL, Kabitz HJ, Laghi F, Langer D, Luo YM, Neder JA, O'Donnell D, Polkey MI, Rabinovich RA, Rossi A, Series F, Similowski T, Spengler CM, Vogiatzis I, Verges S. ERS statement on respiratory muscle testing at rest and during exercise. Eur Respir J. 2019 Jun 13;53(6):1801214. doi: 10.1183/13993003.01214-2018. Print 2019 Jun.
Results Reference
background
PubMed Identifier
16428900
Citation
Bach JR, Goncalves MR, Paez S, Winck JC, Leitao S, Abreu P. Expiratory flow maneuvers in patients with neuromuscular diseases. Am J Phys Med Rehabil. 2006 Feb;85(2):105-11. doi: 10.1097/01.phm.0000197307.32537.40.
Results Reference
background
PubMed Identifier
16055882
Citation
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. doi: 10.1183/09031936.05.00034805. No abstract available.
Results Reference
background
PubMed Identifier
1745285
Citation
Kleyweg RP, van der Meche FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Muscle Nerve. 1991 Nov;14(11):1103-9. doi: 10.1002/mus.880141111.
Results Reference
background
PubMed Identifier
27077919
Citation
Merkies IS, Kieseier BC. Fatigue, Pain, Anxiety and Depression in Guillain-Barre Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Eur Neurol. 2016;75(3-4):199-206. doi: 10.1159/000445347. Epub 2016 Apr 15.
Results Reference
background
PubMed Identifier
7154893
Citation
Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-81.
Results Reference
background
PubMed Identifier
29952780
Citation
Andrews AW, Middleton A. Improvement During Inpatient Rehabilitation Among Older Adults With Guillain-Barre Syndrome, Multiple Sclerosis, Parkinson Disease, and Stroke. Am J Phys Med Rehabil. 2018 Dec;97(12):879-884. doi: 10.1097/PHM.0000000000000991.
Results Reference
background
PubMed Identifier
20298832
Citation
Mong Y, Teo TW, Ng SS. 5-repetition sit-to-stand test in subjects with chronic stroke: reliability and validity. Arch Phys Med Rehabil. 2010 Mar;91(3):407-13. doi: 10.1016/j.apmr.2009.10.030.
Results Reference
background
PubMed Identifier
24388252
Citation
Ferreira PL, Ferreira LN, Pereira LN. [Contribution for the validation of the Portuguese version of EQ-5D]. Acta Med Port. 2013 Nov-Dec;26(6):664-75. Epub 2013 Dec 20. Portuguese.
Results Reference
background
PubMed Identifier
25858974
Citation
Langer D, Charususin N, Jacome C, Hoffman M, McConnell A, Decramer M, Gosselink R. Efficacy of a Novel Method for Inspiratory Muscle Training in People With Chronic Obstructive Pulmonary Disease. Phys Ther. 2015 Sep;95(9):1264-73. doi: 10.2522/ptj.20140245. Epub 2015 Apr 9.
Results Reference
background
PubMed Identifier
26644689
Citation
Jung JH, Kim NS. The effect of progressive high-intensity inspiratory muscle training and fixed high-intensity inspiratory muscle training on the asymmetry of diaphragm thickness in stroke patients. J Phys Ther Sci. 2015 Oct;27(10):3267-9. doi: 10.1589/jpts.27.3267. Epub 2015 Oct 30.
Results Reference
background
PubMed Identifier
27986610
Citation
Angst F, Aeschlimann A, Angst J. The minimal clinically important difference raised the significance of outcome effects above the statistical level, with methodological implications for future studies. J Clin Epidemiol. 2017 Feb;82:128-136. doi: 10.1016/j.jclinepi.2016.11.016. Epub 2016 Dec 14.
Results Reference
background

Learn more about this trial

RehabGBs: Rehabilitation in People With Guillain-Barré Syndrome

We'll reach out to this number within 24 hrs